Evaluation of the effect of HFNC use in COPD patients
Phase 2
Recruiting
- Conditions
- Chronic obstructive pulmonary disease.chronic obstructive pulmonary disease
- Registration Number
- IRCT20160516027929N9
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Signing a written consent form
No intubation
Hypoxemic respiratory distress
Exclusion Criteria
PaCO2> 65
pH < 7.28
Age less than 18 years
Cardiovascular disorders that prevent respiratory rehabilitation
Diagnosis of medical staff based on the patient's absence from participating in this study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Forced expiratory volume in first second. Timepoint: Before starting oxygen therapy, 24 hours later. Method of measurement: Spirometry.;Oxygen saturation. Timepoint: Before starting oxygen therapy, 24 hours later. Method of measurement: Pulse oximetry.;Forced vital capacity. Timepoint: Before starting oxygen therapy, 24 hours later. Method of measurement: Spirometry.;Partial pressure of carbon dioxide. Timepoint: Before starting oxygen therapy, 24 hours later. Method of measurement: VBG analysis.
- Secondary Outcome Measures
Name Time Method Borg scale. Timepoint: Before starting oxygen therapy, 24 hours later. Method of measurement: Questionnaire review.;CAT score. Timepoint: Before starting oxygen therapy, 24 hours later. Method of measurement: Questionnaire review.